PHARMA FAKTEN: Schwächelnde Wirtschaft, alternde Gesellschaft, GKV-Finanzierungskrise und geopolitische Herausforderungen: Tessa Wolf, Leiterin Corporate Affairs bei AstraZeneca in Deutschland, ist…
Daily roundup (02/10/2026) of company regulatory news including AstraZeneca, Bezant Resources, Costain, J D Wetherspoon, Topps Tiles. Research & analysis…
SMMT shares jump as AstraZeneca commits $2 billion to accelerate ivonescimab development and expand clinical collaboration.…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharmaceutical company, has won positive responses from UBS and Jefferies after investing $2…
…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharmaceutical company, will invest $2 billion in Summit Therapeutics Inc. as part of…
AstraZeneca is investing $2 billion in Summit Therapeutics to accelerate the development of PD-1xVEGF bispecific ivonescimab in combination with antibody-drug conjugates…
…
AZNs oncology sales rise 15% in H1 2026 as newer drugs, label expansions and a deep pipeline support continued franchise…
Share price is down after a series of disappointing drug trials…
AZNs Trixeo wins EU approval for asthma, adding an indication backed by phase III data showing improved lung function.…
In the latest trading session, Astrazeneca (AZN) closed at $168.1, marking a +1.22% move from the previous day.…
AstraZeneca wins FDA priority review for efzimfotase alfa, potentially expanding its HPP treatment opportunity with less frequent dosing.…
UBS has told investors that the recent slide in AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares has gone too far, keeping its…
Bad Marienberg (www.aktiencheck.de) - Die Deutsche Bank wird bei der AstraZeneca-Aktie vorsichtig optimistischer. In ihrer AstraZeneca-Aktienanalyse vom 15. September 2026…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) offers the richest run of drug news in the pharmaceuticals sector over the next 18 months,…
Bad Marienberg (www.aktiencheck.de) - Bei AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London Stock Exchange-Symbol: AZN) prallen derzeit zwei…
In the latest trading session, Astrazeneca (AZN) closed at $163.78, marking a +2.25% move from the previous day.…
By Steven Ralston, CFANYSE: VNRXREAD THE FULL VNRX RESEARCH REPORTEXECUTIVE OVERVIEWVolitionRx Limited (NYSE: VNRX) continues to advance its multi-pillar epigenetics…
AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) experimental breast cancer drug camizestrant has failed a late-stage trial, though analysts at Citi say the…
…
…
AstraZeneca breast cancer drug fails late-stage trial goal…
Amgen and AstraZenecas Imdelltra-Imfinzi combo shows survival benefits in first-line ES-SCLC, potentially broadening both drugs reach.…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) drew praise from Deutsche Bank for tozorakimabs lung disease data, but the broker paired its positive…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) drew praise from Deutsche Bank for tozorakimabs lung disease data, but the broker paired its positive…
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca mit einem Kursziel von 11500 Pence auf "Sell" belassen. Der Pharmakonzern…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) drew Citis backing after tozorakimab trial results, supporting an upside case of at least $7 billion…
Amgen and AstraZeneca report positive lung cancer trial results…
Citi has flagged AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) accelerated approval for Etcamah, known chemically as camizestrant, as a meaningful sentiment...…
Citi has flagged AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) accelerated approval for Etcamah, known chemically as camizestrant, as a meaningful sentiment...…
Target changeChange in target pricep 14,380 vs 15,038 -4.38%We have tweaked our earnings estimates lower and considering the recent late-stage…
By Tom Kerr, CFANASDAQ: CTSOREAD THE FULL CTSO RESEARCH REPORTNew Findings Presented at European Society of Cardiology (ESC) Congress 2026On…
AstraZeneca reports positive SANOVO data, showing Tagrisso plus Orpathys improved PFS in first-line EGFR-mutated NSCLC.…
AMD, Costco and AstraZeneca headline todays stock reports, with AI demand, membership growth and drug pipelines shaping their outlooks.…
1 September 2026Notification of Admission of Further Securities to Trading (PRM 1.6.4R)The following notification is made in accordance with The…
1 September 2026Total Voting RightsThe following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure and Transparency…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) said its drug Tezspire worked in a late-stage trial of patients with eosinophilic esophagitis, a chronic…
AstraZeneca’s Tezspire meets trial goals for esophagitis…
AstraZeneca said on Thursday ?its asthma drug, Tezspire, developed with Amgen , ?met its main and secondary goals in a…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharma group, has priced a €2.55 billion bond offering, tapping the euro debt…
FTSE 100 slips 0.06% to 10,810 Airtel Africa and Halma lead early risers AstraZeneca falls around 1% Gold holds near…
FTSE 100 rises 0.2% to 10,838 Mid-caps and AIM move slightly higher Mining, financial and industrial shares lead BP, AstraZeneca…
…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has retained a buy rating from Citi following a mixed set of pipeline updates, with the…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has retained a buy rating from Citi following a mixed set of pipeline updates, with the…
Pharmariese AstraZeneca musste eine Studie für ein wichtiges Lungenkrebsmedikament stoppen. Es ist nicht der erste Fehlschlag in der jüngsten Zeit.…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has reported positive results from a late-stage trial of a two-drug combination for a hard-to-treat form of…
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has suffered its second pipeline setback in little over a month after halting a late-stage lung cancer…
FTSE 100 up 4 at 10,755 Miners recover ground AZ resilient Posh house prices hit 10.55am: Drugmaker misses AstraZeneca shares proved…